Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.48
-0.03 (-1.99%)
At close: Aug 15, 2025, 3:58 PM
1.47
-0.68%
After-hours: Aug 15, 2025, 04:00 PM EDT
Sunshine Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 9.69M | 12.21M | 11.51M | 17.43M | 16.29M | 18.85M | 19.73M | 19.29M | 21.83M | 40.56M | 41.73M | 13.18M | 2.05M | 2.39M | 1.74M | 1.8M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | -2.31M | n/a | -1.93M | -3.77K | -1.64K | n/a | n/a | n/a | n/a | n/a |
Receivables | 3.87M | 3.22M | 3.97M | 2.83M | 2.55M | 2.03M | 2.01M | 1.79M | 1.91M | 22.00 | 24.00 | 24.00 | 7.8K | 1.13K | n/a | n/a |
Inventory | 11.28M | 9.82M | 8.49M | 7.7M | 5.73M | 4.52M | 4.25M | 3.71M | 3.29M | 269.64K | 205.37K | 181.5K | 105.65K | 71.31K | 45.22K | 26.66K |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.59K | n/a | n/a | 7.59K | 7.59K | 7.59K | n/a |
Total Current Assets | 25.97M | 25.98M | 25.75M | 28.83M | 24.89M | 25.43M | 26.1M | 24.95M | 27.31M | 40.86M | 41.99M | 13.41M | 2.2M | 2.49M | 1.8M | 1.84M |
Property-Plant & Equipment | 1.48M | 1.13M | 1.11M | 1M | 1.01M | 999.22K | 1.08M | 1.1M | 1.15M | 3.77K | 1.64K | 3.98K | 7.06K | 10.23K | 13.48K | 16.63K |
Goodwill & Intangibles | 3.02M | 2.94M | 2.45M | 2.07M | 1.44M | 1.22M | 1.23M | 948.24K | 776.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.59M | 4.07M | 3.55M | 3.07M | 2.46M | 2.22M | 2.31M | 2.04M | 1.93M | 3.77K | 1.64K | 3.98K | 7.06K | 10.23K | 13.48K | 16.63K |
Total Assets | 30.56M | 30.06M | 29.3M | 31.9M | 27.35M | 27.65M | 28.41M | 26.99M | 29.24M | 40.86M | 41.99M | 13.41M | 2.2M | 2.5M | 1.82M | 1.86M |
Account Payables | 5.54M | 4.16M | 4.93M | 3.62M | 2.59M | 2.22M | 1.76M | 2.74M | 2.8M | 480.21K | 104.68K | 95.23K | 42.94K | 56.69K | 103.19K | 148.56K |
Deferred Revenue | n/a | n/a | -114.45K | 254.97K | 299.87K | -2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.63M | n/a | n/a | n/a | n/a | 330K | 473.66K | 664.69K |
Other Current Liabilities | 295.8K | n/a | 254.97K | 2.55M | 2.85M | 2.75M | 2.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 6.31M | 4.53M | 5.3M | 6.53M | 5.55M | 5.09M | 4.66M | 6.91M | 6.93M | 480.21K | 104.68K | 95.23K | 91.23K | 471.63K | 635.56K | 864.79K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.9M | 3.2M | 2.05M | 2.08M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 744.72K | 489.03K | 511.63K | 545.7K | 587.76K | 598.72K | 639.88K | 656.17K | 685.26K | 480.21K | 104.68K | 95.23K | 1.9M | 3.2M | 2.05M | 2.08M |
Total Liabilities | 7.06M | 5.02M | 5.81M | 7.08M | 6.14M | 5.69M | 5.3M | 7.56M | 7.62M | 480.21K | 104.68K | 95.23K | 1.99M | 3.68M | 2.69M | 2.94M |
Total Debt | 952.48K | 556.55K | 577.36K | 612.37K | 657.71K | 673.53K | 719K | 734.44K | 4.27M | n/a | n/a | n/a | 1.9M | 3.53M | 2.53M | 2.74M |
Common Stock | 2.58K | 2K | 1.17K | 995.00 | 28.02K | 25.68K | 25.75K | 22.14K | 22.59K | 18.89K | 18.89K | 7.15K | 2.59K | 510.09K | 486.09K | 465K |
Retained Earnings | -69.04M | -66.88M | -65.68M | -65.19M | -63.91M | -62.66M | -62M | -61.1M | -59.4M | -35.89M | -34.43M | -33.89M | -32.66M | -33.32M | -29.28M | -26.4M |
Comprehensive Income | -829.96K | 168.59K | -683.05K | 152.4K | 696.11K | 204.55K | 665.06K | 173.01K | 161.85K | -79.9K | -34.78K | -22.13K | -23.14K | -17.48K | -11.64K | -4.93K |
Shareholders Equity | 23.5M | 25.04M | 23.49M | 24.82M | 21.21M | 21.96M | 23.11M | 19.43M | 21.63M | 40.38M | 41.89M | 13.31M | 211.66K | -1.17M | -872.71K | -1.08M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K | 7.59K |